Tongling Jieya Biologic Technology Co., Ltd. Share Price
Equities
301108
CNE1000054S9
Personal Products
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.18 CNY | -0.15% | +3.74% | -21.31% |
Sales 2024 * | 720M 99.45M 7.93B | Sales 2025 * | 825M 114M 9.09B | Capitalization | 2.21B 305M 24.3B |
---|---|---|---|---|---|
Net income 2024 * | 134M 18.51M 1.48B | Net income 2025 * | 157M 21.69M 1.73B | EV / Sales 2024 * | 3.06 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.67 x |
P/E ratio 2024 * |
16.4
x | P/E ratio 2025 * |
-
| Employees | 683 |
Yield 2024 * |
1.55% | Yield 2025 * |
1.8% | Free-Float | 28.37% |
1 day | -0.15% | ||
1 week | +3.74% | ||
Current month | -3.55% | ||
1 month | -3.55% | ||
3 months | -8.18% | ||
6 months | -21.38% | ||
Current year | -21.31% |
Managers | Title | Age | Since |
---|---|---|---|
Ying Chuan Cai
CEO | Chief Executive Officer | 54 | 30/08/99 |
Yun Feng Lu
CHM | Chairman | 41 | 31/07/18 |
Xian Guo Yuan
ADM | Chief Administrative Officer | 55 | 31/03/04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yun Feng Lu
CHM | Chairman | 41 | 31/07/18 |
Ying Chuan Cai
CEO | Chief Executive Officer | 54 | 30/08/99 |
Yan Feng
BRD | Director/Board Member | 50 | 31/07/99 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 12 M€ | -16.71% | - |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 27.18 | -0.15% | 232,549 |
29/04/24 | 27.22 | +1.26% | 422,173 |
26/04/24 | 26.88 | -0.15% | 231,700 |
25/04/24 | 26.92 | +2.32% | 407,500 |
24/04/24 | 26.31 | +0.04% | 265,100 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.31% | 305M | |
+12.38% | 45.95B | |
-8.12% | 17.68B | |
+3.08% | 3.61B | |
+4.54% | 2.6B | |
-11.10% | 1.61B | |
+42.48% | 1.28B | |
+17.63% | 960M | |
+22.68% | 820M | |
+29.01% | 449M |
- Stock Market
- Equities
- 301108 Stock